Caseware UK (AP4) 2023.0.135 2023.0.135 2024-10-312024-10-312025-05-09false2023-11-01false3General medical practice activities3truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 14424799 2023-11-01 2024-10-31 14424799 2022-10-17 2023-10-31 14424799 2024-10-31 14424799 2023-10-31 14424799 c:Director2 2023-11-01 2024-10-31 14424799 d:OfficeEquipment 2023-11-01 2024-10-31 14424799 d:OfficeEquipment 2024-10-31 14424799 d:OfficeEquipment 2023-10-31 14424799 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-11-01 2024-10-31 14424799 d:ComputerEquipment 2023-11-01 2024-10-31 14424799 d:ComputerEquipment 2024-10-31 14424799 d:ComputerEquipment 2023-10-31 14424799 d:ComputerEquipment d:OwnedOrFreeholdAssets 2023-11-01 2024-10-31 14424799 d:OtherPropertyPlantEquipment 2023-11-01 2024-10-31 14424799 d:OtherPropertyPlantEquipment 2024-10-31 14424799 d:OtherPropertyPlantEquipment 2023-10-31 14424799 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2023-11-01 2024-10-31 14424799 d:OwnedOrFreeholdAssets 2023-11-01 2024-10-31 14424799 d:PatentsTrademarksLicencesConcessionsSimilar 2023-11-01 2024-10-31 14424799 d:PatentsTrademarksLicencesConcessionsSimilar 2024-10-31 14424799 d:PatentsTrademarksLicencesConcessionsSimilar 2023-10-31 14424799 d:CurrentFinancialInstruments 2024-10-31 14424799 d:CurrentFinancialInstruments 2023-10-31 14424799 d:CurrentFinancialInstruments d:WithinOneYear 2024-10-31 14424799 d:CurrentFinancialInstruments d:WithinOneYear 2023-10-31 14424799 d:ShareCapital 2024-10-31 14424799 d:ShareCapital 2023-10-31 14424799 d:RetainedEarningsAccumulatedLosses 2024-10-31 14424799 d:RetainedEarningsAccumulatedLosses 2023-10-31 14424799 c:FRS102 2023-11-01 2024-10-31 14424799 c:AuditExempt-NoAccountantsReport 2023-11-01 2024-10-31 14424799 c:FullAccounts 2023-11-01 2024-10-31 14424799 c:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 14424799 d:PatentsTrademarksLicencesConcessionsSimilar d:ExternallyAcquiredIntangibleAssets 2023-11-01 2024-10-31 14424799 d:PatentsTrademarksLicencesConcessionsSimilar d:OwnedIntangibleAssets 2023-11-01 2024-10-31 14424799 e:PoundSterling 2023-11-01 2024-10-31 iso4217:GBP xbrli:pure

Registered number: 14424799










FAMILY MEDICAL GROUP LTD








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 OCTOBER 2024

 
FAMILY MEDICAL GROUP LTD
REGISTERED NUMBER: 14424799

BALANCE SHEET
AS AT 31 OCTOBER 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 4 
153
-

Tangible assets
 5 
8,757
9,294

  
8,910
9,294

Current assets
  

Debtors: amounts falling due within one year
 6 
6,530
872

Cash at bank and in hand
  
4,649
6,627

  
11,179
7,499

Creditors: amounts falling due within one year
 7 
(15,783)
(34,945)

Net current liabilities
  
 
 
(4,604)
 
 
(27,446)

Total assets less current liabilities
  
4,306
(18,152)

  

Net assets/(liabilities)
  
4,306
(18,152)


Capital and reserves
  

Called up share capital 
  
4
4

Profit and loss account
  
4,302
(18,156)

  
4,306
(18,152)


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 9 May 2025.


Page 1

 
FAMILY MEDICAL GROUP LTD
REGISTERED NUMBER: 14424799
    
BALANCE SHEET (CONTINUED)
AS AT 31 OCTOBER 2024



Nick Prince
Director

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
FAMILY MEDICAL GROUP LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024

1.


General information

Family Medical Group Ltd is a private company limited by shares incorporated in England and Wales in the United Kingdom. The address of the registered office is 34 Chapel Street, East Malling, West Malling, ME19 6AP.
The financial statements are presented in sterling which is the functional currency of the company and is rounded to the nearest £1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

Page 3

 
FAMILY MEDICAL GROUP LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024

2.Accounting policies (continued)

 
2.4

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 Amortisation is provided on the following bases:

Patents
-
10%
straight line basis

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
20%
straight line basis
Computer equipment
-
20%
straight line basis
Medical equipment
-
20%
straight line basis

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 4

 
FAMILY MEDICAL GROUP LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024

2.Accounting policies (continued)

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

2024
2023
£
£

Wages and salaries
35,215
-

Social security costs
3,412
-

38,627
-


The average monthly number of employees, including directors, during the year was 3 (2023 - 3).


4.


Intangible assets




Patents

£



Cost


Additions
170



At 31 October 2024

170



Amortisation


Charge for the year on owned assets
17



At 31 October 2024

17



Net book value



At 31 October 2024
153



At 31 October 2023
-



Page 5

 
FAMILY MEDICAL GROUP LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024

5.


Tangible fixed assets





Office equipment
Computer equipment
Medical equipment
Total

£
£
£
£



Cost or valuation


At 1 November 2023
6,398
319
4,837
11,554


Additions
738
-
1,151
1,889



At 31 October 2024

7,136
319
5,988
13,443



Depreciation


At 1 November 2023
1,280
64
916
2,260


Charge for the year on owned assets
1,427
64
935
2,426



At 31 October 2024

2,707
128
1,851
4,686



Net book value



At 31 October 2024
4,429
191
4,137
8,757



At 31 October 2023
5,118
255
3,921
9,294


6.


Debtors

2024
2023
£
£


Trade debtors
5,778
120

Other debtors
752
752

6,530
872


Page 6

 
FAMILY MEDICAL GROUP LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024

7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
-
241

Other creditors
12,633
31,704

Accruals and deferred income
3,150
3,000

15,783
34,945


 
Page 7